A Few Key Points I Am Focusing On From Gilead Sciences' Upcoming Earnings Release
GILD's first-quarter earnings release [on 4/28, confirmed by Wall Street Horizon on 4/4] remains the most widely anticipated event of the quarter...
Read MoreData-as-a-Service Analytics Startup Kyper Taps WSH for Events Data
Kyper has incorporated content from Wall Street Horizon into its platform, to allow users to consider events data alongside other sources to create predictive signals based on historical analysis.
Read MoreWall Street Horizon Data to Be Offered Through Kyper's Revolutionary New Data-as-a-Service Platform
“We are thrilled to be on the platform and believe it will help more firms develop alpha generating strategies using our corporate event data.
Read MoreUpdating My Outlook On Pfizer In Light Of The Recent Termination Of The Allergan Merger
See how corporate events such as upcoming the earnings announcement affect the outlook for PFE..
Read MoreRegeneron Pharmaceuticals Is My Top Pick In The Biotech Space
Article includes shapshot of corporate event data from Wall Street Horizon as it factors into the analysis of REGN...
Read MoreMy Thoughts On Gilead Sciences' Patent Loss
How will Gilead's forthcoming earnings release impact the share price? Check out Seeking Alpha's detailed analysis...
Read MoreAbbVie Superior Dividend Makes It A Top Choice In The Health Care Sector
Critical corporate event data from Wall Street Horizon featured as author Alexander Poulos delves into the growth of ABBV...
Read More